CRT 2026

Panel Discussion | Expert Strategies for Mitral and Tricuspid Success

Moderator(s)

• 

  Zuyue Wang, MD

  In transition
  In transition
  Plano, Texas, United States

  Disclosure(s): No financial relationships to disclose
• 

  Dee Dee Wang, MD

  Section Head Cardiac Imaging
  NCH Rooney Heart Institute, Michigan, United States

  Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

• ME

  Marvin Eng, MD

  Section Chief, Interventional Cardiology Structural Heart Medical Director
  University of Nebraska Medical Center
  Omaha, Nebraska, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Vijay Iyer, MD, PhD

  Associate Professor
  University at Buffalo
  East Amherst, New York, United States

  Disclosure(s): Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Otsuka Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  James McCabe, MD

  Section Chief, Interventional Cardiology
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.